Experts from Cleveland Clinic’s kidney transplant and infectious disease programs respond to urgent calls for improved organ utilization efforts.
For people with chronic kidney disease, daily low-dose aspirin use doesn’t appear to confer either primary or secondary cardiovascular benefit. On the other hand, it also doesn’t seem to accelerate kidney disease progression or cause major bleeding.
A Cleveland Clinic nephrologist discusses the landmark studies that have enabled the availability of new treatment options for managing diabetic kidney disease.
Nephrologists talk about the need for disruption in kidney medicine and two clinical trials poised to set the stage for more individualized care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Urology and nephrology, both traditionally male-dominated specialties, are attracting more women. Crystal Gadegbeku, MD, Chair of Cleveland Clinic’s Department of Kidney Medicine, comments on the importance of diversity in medicine.